Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China
· Delayed Price · Currency is CNY 13.92
-0.04 (-0.29%)
May 13, 2025, 2:45 PM CST
SHE:000739 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 16,126 | 18,836 | 17,996 | 25,222 | 41,354 | 27,436 | Upgrade
|
| Market Cap Growth | 18.73% | 4.67% | -28.65% | -39.01% | 50.73% | 79.49% | Upgrade
|
| Enterprise Value | 13,431 | 15,909 | 15,202 | 22,812 | 39,127 | 25,105 | Upgrade
|
| Last Close Price | 13.92 | 16.26 | 15.08 | 20.78 | 33.46 | 22.02 | Upgrade
|
| PE Ratio | 15.63 | 18.27 | 17.05 | 25.50 | 43.28 | 33.59 | Upgrade
|
| Forward PE | 13.17 | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | Upgrade
|
| PS Ratio | 1.40 | 1.57 | 1.57 | 2.39 | 4.62 | 3.48 | Upgrade
|
| PB Ratio | 2.30 | 2.79 | 2.89 | 4.57 | 8.17 | 6.25 | Upgrade
|
| P/TBV Ratio | 2.42 | 2.94 | 3.06 | 4.89 | 8.81 | 6.81 | Upgrade
|
| P/FCF Ratio | 30.86 | 25.18 | 44.89 | 30.87 | - | 36.96 | Upgrade
|
| P/OCF Ratio | 17.65 | 15.58 | 17.45 | 19.02 | 67.60 | 25.90 | Upgrade
|
| EV/Sales Ratio | 1.16 | 1.32 | 1.33 | 2.16 | 4.38 | 3.19 | Upgrade
|
| EV/EBITDA Ratio | 8.78 | 10.10 | 9.32 | 17.60 | 29.69 | 21.50 | Upgrade
|
| EV/EBIT Ratio | 14.16 | 15.72 | 14.11 | 25.16 | 40.78 | 30.48 | Upgrade
|
| EV/FCF Ratio | 25.70 | 21.27 | 37.92 | 27.92 | - | 33.82 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.14 | 0.15 | 0.15 | 0.09 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.50 | 0.57 | 0.56 | 0.65 | 0.36 | 0.28 | Upgrade
|
| Debt / FCF Ratio | 1.46 | 1.22 | 2.30 | 1.02 | - | 0.45 | Upgrade
|
| Asset Turnover | 0.88 | 0.94 | 0.93 | 1.00 | 1.08 | 1.12 | Upgrade
|
| Inventory Turnover | 5.04 | 4.68 | 4.44 | 5.29 | 5.63 | 5.48 | Upgrade
|
| Quick Ratio | 1.12 | 1.05 | 0.94 | 0.95 | 1.13 | 1.25 | Upgrade
|
| Current Ratio | 1.51 | 1.43 | 1.33 | 1.29 | 1.53 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 15.37% | 15.88% | 17.96% | 18.70% | 20.22% | 20.02% | Upgrade
|
| Return on Assets (ROA) | 4.53% | 4.96% | 5.44% | 5.38% | 7.25% | 7.34% | Upgrade
|
| Return on Capital (ROIC) | 7.80% | 8.54% | 9.97% | 9.53% | 11.69% | 12.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.10% | 14.50% | 16.70% | 15.10% | 18.20% | 17.90% | Upgrade
|
| Earnings Yield | 6.42% | 5.47% | 5.86% | 3.92% | 2.31% | 2.98% | Upgrade
|
| FCF Yield | 3.24% | 3.97% | 2.23% | 3.24% | -0.22% | 2.71% | Upgrade
|
| Dividend Yield | 2.55% | 2.19% | 2.10% | 1.43% | 0.85% | 1.10% | Upgrade
|
| Payout Ratio | 38.29% | 38.95% | 36.29% | 36.68% | 31.60% | 24.65% | Upgrade
|
| Buyback Yield / Dilution | 0.54% | 0.52% | 0.40% | 0.38% | 0.00% | -0.01% | Upgrade
|
| Total Shareholder Return | 3.09% | 2.71% | 2.51% | 1.80% | 0.85% | 1.09% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.